| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Justin De Four CEO | OTC PINK Exchange | 09076L103 CUSIP |
| US Country | 3 Employees | - Last Dividend | 23 Jul 2018 Last Split | - IPO Date |
Bio Life Sciences Corp. is an innovative company that engages in the development, licensing, and distribution of a variety of antibacterial products as well as non-contact human temperature screening technology. Established in 2018, the company is headquartered in Mississauga, Canada, marking its presence in the field of hygiene and health technology. Bio Life Sciences Corp. is dedicated to offering solutions that promote health and safety in both personal and public spaces, leveraging advanced technology and research to meet the demands of modern health concerns.
The product lineup and services offered by Bio Life Sciences Corp. are diverse, catering to the needs of disinfection and health monitoring in various environments. These include: